UK privately-held T-regulatory (Treg) cell therapies developer Quell Therapeutics today revealed that pharma major ...

Last month, the Future Health Report was presented at the World Health Assembly in Geneva, Switzerland. The report states ...

A fresh attempt to bring more pharmaceutical manufacturing back to US soil has put the sector on alert, as a new executive ...

Oxford, UK-based biotech SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease ...

UK-based microbiome company Microbiotica has appointed Robert Tansley its chief medical officer (CMO).

New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, closed Monday’s trading nearly ...

Privately-owned German biotech XL-protein GmbH today announced that it has entered into a worldwide license, development and ...

US Health Secretary Robert F Kennedy Jr has removed all 17 members of a key vaccine advisory committee, a move officials say ...

Dutch late-stage biotech NewAmsterdam Pharma (Nasdaq: NAMS) late yesterday announced positive top-line data from prespecified ...

Swiss pharma company Idorsia (SIX: IDIA) today announced the appointment of Dr Srishti Gupta as chief executive (CEO), ...

Specialty immunotherapy company Tevogen Bio Holdings has announced the execution of a lease agreement to expand its corporate ...

Africa is grappling with a worsening mpox crisis, with a critical shortfall of vaccine doses threatening to derail ...